Cardiac Dimensions, Intraventricular Septum Thickness in Relation to the Estimated Glucose Disposal Rate Individuals with Long-Standing Type 1 Diabetes: A Cross-Sectional Analysis of the PARADISE T1DM Study
DOI:
https://doi.org/10.20883/medical.e1124Keywords:
type 1 diabetes, echocardiography, insulin resistance, left ventricleAbstract
Aim. Insulin can stimulate the growth of various cells, including cardiomyocytes, through the insulin-like growth factor (IGF) signaling pathway. Insulin resistance (IR), characterized by elevated circulating insulin levels, complicates long-standing type 1 diabetes mellitus (T1DM). This study investigates whether IR in T1DM is associated with cardiac remodeling.
Material and methods. IR was assessed using the estimated glucose disposal rate (eGDR) in 84 adults with T1DM of at least 5 years. Participants with an eGDR at or below the median value were considered more insulin resistant. Transthoracic echocardiography was used to measure left ventricular end-diastolic diameter (LVEDD), intraventricular septal thickness (IVST), right ventricular end-diastolic diameter (RVEDD), and left atrial diameter (LAD). Participants were divided into two groups based on the median eGDR value. Comparisons between groups were made using the Mann-Whitney test.
Results. The median age of the participants was 40.5 years (range: 34.0-51.0), with a T1DM duration of 21.0 years (range: 15.5-27.0) and eGDR of 7.4 (range: 5.1-9.5). Of the participants, 52 (61.9%) were men. Individuals with lower eGDR had larger cardiac diameters (all in cm): LVEDD (4.5 [4.3-4.8] vs 4.75 [4.5-5]; p=0.01), LVEDD(2.7 [2.5-2.8] vs 2.8 [2.6-2.9]; p=0.02), end-systolic LAD (3.5 [3.2-3.7] vs 3.8 [3.5-3.9]; p<0.01), and thicker IVS (0.9 [0.8-1] vs 1.1 [1-1.18]; p<0.01).
Conclusions. Individuals with T1DM and lower eGDR values exhibited more pronounced cardiac remodeling, with greater LVEDD, RVEDD, and LAD dilation and increased IVST. These findings suggest that people with T1DM at risk of IR have more commonly adverse cardiac structural changes, though causality remains uncertain.
Downloads
References
Araszkiewicz A et al 2022 Guidelines on the management of patients with diabetes. Current Topics in Diabetes 2022 | Curr Top Diabetes, 2022; 2 (1): 1–134.
Mao Y, Zhong W (2022) Changes of insulin resistance status and development of complications in type 1 diabetes mellitus: Analysis of DCCT/EDIC study. Diabetes Res Clin Pract 184:109211
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-223
Epstein EJ, Osman JL, Cohen HW, Rajpathak SN, Lewis O, Crandall JP (2013) Use of the Estimated Glucose Disposal Rate as a Measure of Insulin Resistance in an Urban Multiethnic Population With Type 1 Diabetes. Diabetes Care 36:2280–2285
Šimonienė D, Platūkiene A, Prakapienė E, Radzevičienė L, Veličkiene D (2020) Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient’s Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data. Diabetes Ther 11:161–174
Garofolo M, Gualdani E, Scarale MG, et al (2020) Insulin Resistance and Risk of Major Vascular Events and All-Cause Mortality in Type 1 Diabetes: A 10-Year Follow-up Study. Diabetes Care 43:e139–e141
Avogaro A, Azzolina D, Fadini GP, Baldi I (2021) Incidence of heart failure in patients with type 1 diabetes: a systematic review of observational studies. J Endocrinol Invest 44:745–753
Katogiannis K, Vlastos D, Kousathana F, Thymis J, Kountouri A, Korakas E, Plotas P, Papadopoulos K, Ikonomidis I, Lambadiari V (2020) Echocardiography, an Indispensable Tool for the Management of Diabetics, with or without Coronary Artery Disease, in Clinical Practice. Medicina. https://doi.org/10.3390/medicina56120709
Jia G, Whaley-Connell A, Sowers JR (2018) Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia 61:21
Liu JJ, Liu S, Ang KA, Lim SC (2023) Estimated glucose disposal rate, a novel biomarker for insulin sensitivity, predicts risk for incident heart failure in patients with type 2 diabetes. European Heart Journal 44:ehac779.035
Weber TR, da Silva RL, Cossul S, Alves MSL, Lee SV der S, Marques JLB (2021) The use of echocardiography in type 1 diabetes. Rev Port Cardiol (Engl Ed) S0870-2551(21)00249–3
Šuran D, Kanič V, Naji F, Krajnc I, Čokolič M, Zemljič E, Sinkovič A (2019) Predictors of early cardiac changes in patients with type 1 diabetes mellitus: An echocardiography-based study. Biomolecules and Biomedicine 19:384–391
Sawicka-Gutaj N, Gruszczyński D, Guzik P, Mostowska A, Walkowiak J (2022) Publication ethics of human studies in the light of the Declaration of Helsinki – a mini-review. Journal of Medical Science 91:e700–e700
Kulecki M, Naskret D, Kaminski M, Kasprzak D, Lachowski P, Klause D, Kozlowska M, Flotynska J, Uruska A, Zozulinska-Ziolkiewicz D (2021) Association between central non-dipping pattern and platelet morphology in adults with type 1 diabetes without cardiovascular disease: a cross-sectional study. Sci Rep 11:15416
Kulecki M, Naskret D, Kaminski M, Kasprzak D, Lachowski P, Klause D, Kozlowska M, Flotynska J, Uruska A, Zozulinska-Ziolkiewicz D (2023) Arterial stiffness and the non-dipping pattern in type 1 diabetes males with and without erectile dysfunction. Sci Rep 13:7265
Kamiński M, Kulecki M, Lachowski P, Kasprzak D, Kulczycka A, Kozłowska M, Klause D, Uruska A, Michalski M, Zozulińska-Ziółkiewicz D (2022) Erectile Dysfunction in Individuals with Type 1 Diabetes is Associated with Long-term Metabolic Control and Diabetic Complications: A Cross-Sectional Study. Int J Angiol 31:97–106
Galderisi M, Cosyns B, Edvardsen T, et al (2017) Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 18:1301–1310
Lipiec P, Bąk J, Braksator W, et al. Transthoracic echocardiography in adults — guidelines of the Working Group on Echocardiography of the Polish Cardiac Society. Kardiol Pol. 2018; 76(2): 488–493, doi: 10.5603/KP.2018.0051.
Guzik P, Więckowska B (2023) Data distribution analysis – a preliminary approach to quantitative data in biomedical research. Journal of Medical Science 92:e869–e869
Lang RM, Badano LP, Mor-Avi V, et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1-39.e14
Pfaffenberger S, Bartko P, Graf A, Pernicka E, Babayev J, Lolic E, Bonderman D, Baumgartner H, Maurer G, Mascherbauer J (2013) Size Matters! Impact of Age, Sex, Height, and Weight on the Normal Heart Size. Circulation: Cardiovascular Imaging 6:1073–1079
Zhu N, Chen H, Zhao X, Ye F, Jiang W, Wang Y (2019) Left atrial diameter in heart failure with left ventricular preserved, mid-range, and reduced ejection fraction. Medicine (Baltimore) 98:e18146
Hirose K, Nakanishi K, Daimon M, et al (2021) Impact of insulin resistance on subclinical left ventricular dysfunction in normal weight and overweight/obese japanese subjects in a general community. Cardiovasc Diabetol 20:22
Sakthivadivel V, Chinnathambi C, Selvaraju D, Gaur A, Bakthavatchalam R, Srivijayan A, Sundaramurthy R, Tadi LJ, John NA (2023) Metabolic syndrome - cardiac structure and functional analysis by echocardiography; a cross sectional comparative study. Horm Mol Biol Clin Investig 44:305–310
Left Ventricular Diameter and Risk Stratification for Sudden Cardiac Death | Journal of the American Heart Association. https://www.ahajournals.org/doi/10.1161/JAHA.114.001193. Accessed 15 Aug 2024
Otowa-Suematsu N, Sakaguchi K, Kaneko A, et al (2021) Relation of cardiac function to insulin resistance as evaluated by hyperinsulinemic-euglycemic clamp analysis in individuals with type 2 diabetes. Journal of Diabetes Investigation 12:2197–2202
Diabetes mellitus in patients with heart failure and effect modification of risk factors for short-term mortality: An observational study from the Registro Colombiano de Falla Cardíaca (RECOLFACA) - PubMed. https://pubmed.ncbi.nlm.nih.gov/39079149/. Accessed 15 Aug 2024
Zhang J, Yang Z, Fan X, Fei Q, Xi Y (2024) Positive Correlation between BMI and Left Ventricle and Atrium Inside Diameter Size in Chinese Type 2 Diabetes Patients with Left Ventricular and Atrial Enlargement. Rev Cardiovasc Med 25:207
Khoury S, Zornitzki L, Laufer-Perl M, et al (2024) Sex-related differences in the association between septal wall thickness and survival. IJC Heart & Vasculature 53:101427
Fazio S, Mercurio V, Tibullo L, Fazio V, Affuso F (2024) Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated. Front Cardiovasc Med 11:1380506
Abel ED (2021) Insulin signaling in the heart. Am J Physiol Endocrinol Metab 321:E130–E145
Cai W, Sakaguchi M, Kleinridders A, et al (2017) Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression. Nat Commun 8:14892
Madonna R, Pandolfi A, Massaro M, Consoli A, De Caterina R (2004) Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 47:532–536
Stout RW (1991) Insulin as a mitogenic factor: role in the pathogenesis of cardiovascular disease. Am J Med 90:62S-65S
Paternostro G, Pagano D, Gnecchi-Ruscone T, Bonser RS, Camici PG (1999) Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 42:246–253
Shi H, Chu H, Lv Z, Qi G, Guo J, Fu W, Wang X, Guo X, Ge J, Yin C (2017) Association of white blood cell counts with left ventricular mass index in hypertensive patients undergoing anti-hypertensive drug therapy. Exp Ther Med 13:1566–1571
Bajpai A, Tilley DG (2018) The Role of Leukocytes in Diabetic Cardiomyopathy. Front Physiol 9:1547
Jensen MT, Sogaard P, Gustafsson I, et al (2019) Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study. Diabetologia 62:2354–2364
Lassen MCH, Biering-Sørensen T, Jørgensen PG, Andersen HU, Rossing P, Jensen MT (2021) Sex differences in the association between myocardial function and prognosis in type 1 diabetes without known heart disease: the Thousand & 1 Study. Eur Heart J Cardiovasc Imaging 22:1017–1025
Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson A-M, Rosengren A (2011) Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet 378:140–146
Hjortkjær HØ, Jensen T, Hilsted J, et al (2019) Cardiac ventricular sizes are reduced in patients with long-term, normoalbuminuric type 1 diabetes compared to the non-diabetic background population. Diab Vasc Dis Res 16:289–296
Wamil M, Coleman RL, Adler AI, McMurray JJV, Holman RR (2021) Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89. Diabetes Care 44:1877–1884
Dereziński T, Zozulińska-Ziółkiewicz D, Uruska A, Dąbrowski M. Visceral adiposity index as a useful tool for the assessment of cardiometabolic disease risk in women aged 65 to 74. Diabetes Metab Res Rev. 2018 Nov;34(8):e3052. doi: 10.1002/dmrr.3052.
Published
Issue
Section
License
Copyright (c) 2024 The copyright to the submitted manuscript is held by the Author, who grants the Journal of Medical Science (JMS) a nonexclusive licence to use, reproduce, and distribute the work, including for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.